ES2025560T3 - Un procedimiento para preparar una composicion para el tratamiento alimenticio. - Google Patents

Un procedimiento para preparar una composicion para el tratamiento alimenticio.

Info

Publication number
ES2025560T3
ES2025560T3 ES198686402806T ES86402806T ES2025560T3 ES 2025560 T3 ES2025560 T3 ES 2025560T3 ES 198686402806 T ES198686402806 T ES 198686402806T ES 86402806 T ES86402806 T ES 86402806T ES 2025560 T3 ES2025560 T3 ES 2025560T3
Authority
ES
Spain
Prior art keywords
preparing
procedure
composition
amino acids
salt mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686402806T
Other languages
English (en)
Inventor
Mackenzie Walser
Henri Bermudez
Claude Bordat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Johns Hopkins University
Original Assignee
Synthelabo SA
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA, Johns Hopkins University filed Critical Synthelabo SA
Application granted granted Critical
Publication of ES2025560T3 publication Critical patent/ES2025560T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

MEZCLAS DE SALES MIXTAS FORMADAS ENTRE ALFA CETOACIDOS DE CADENA RAMIFICADA Y L-AMINOACIDOS BASICOS SON UTILES PARA EL TRATAMIENTO NUTRITIVO DEL FALLO RENAL CRONICO(UREMIA). ESTAS COMPOSICIONES CONTIENEN MENOS SALES COMPONENTES QUE OTRAS MEZCLAS DE SALES QUE CONTIENEN IGUALES PROPORCIONES DE AMINOACIDOS BASICOS Y CETOACIDOS. LAS COMPOSICIONES SE PUEDEN UTILIZAR CONJUNTAMENTE CON UNA DIETA DE CALIDAD PROTEINICA MIXTA DE 20-30 G/DIA Y UN SUPLEMENTO VITAMINICO Y MINERAL.
ES198686402806T 1985-12-23 1986-12-16 Un procedimiento para preparar una composicion para el tratamiento alimenticio. Expired - Lifetime ES2025560T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/812,164 US4752619A (en) 1985-12-23 1985-12-23 Nutritional supplement for treatment of uremia

Publications (1)

Publication Number Publication Date
ES2025560T3 true ES2025560T3 (es) 1992-04-01

Family

ID=25208721

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686402806T Expired - Lifetime ES2025560T3 (es) 1985-12-23 1986-12-16 Un procedimiento para preparar una composicion para el tratamiento alimenticio.

Country Status (14)

Country Link
US (1) US4752619A (es)
EP (1) EP0227545B1 (es)
JP (1) JPS62270522A (es)
KR (1) KR940002661B1 (es)
AT (1) ATE67088T1 (es)
AU (1) AU592395B2 (es)
CA (1) CA1286990C (es)
DE (1) DE3681420D1 (es)
DK (2) DK168274B1 (es)
ES (1) ES2025560T3 (es)
FI (1) FI88581C (es)
GR (1) GR3003272T3 (es)
NO (1) NO865217L (es)
PT (1) PT83995B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
SE8803143L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Alternativa energisubstrat
SE8803144L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Energisubstrat
GB8906158D0 (en) * 1989-03-17 1989-05-04 Powell & Scholefield Limited Dietary product
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
ATE405287T1 (de) * 1998-01-05 2008-09-15 Univ Johns Hopkins Diätetische ergänzung für dialyse patienten
JP2004527529A (ja) * 2001-04-04 2004-09-09 クリティカル セラピューティックス インコーポレイテッド 急性腎不全を予防するための方法
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
CN101217960B (zh) 2005-07-08 2010-12-15 东丽株式会社 用于改善尿毒症的治疗药和处置方法
JP2014511890A (ja) 2011-04-18 2014-05-19 ネステク ソシエテ アノニム α−ＨＩＣＡ及びα−ケトグルタル酸を含有する栄養組成物
US11253496B2 (en) 2017-11-29 2022-02-22 Edgar L. Hull Alpha keto acid compositions for treating hypo-albuminemia
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
US12109254B2 (en) 2017-11-29 2024-10-08 Edgar Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
GB1442154A (en) * 1973-04-30 1976-07-07 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body
DE2516027A1 (de) * 1973-04-30 1975-10-16 Univ Johns Hopkins Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper
DE2759133A1 (de) * 1976-12-31 1978-07-13 Carmelo Prof Giordano Gemisch essentieller aminosaeuren und/oder analoger ketosaeuren und verwendung derselben diaetzusatz bei niereninsuffizienz
US4320146A (en) * 1978-03-17 1982-03-16 The Johns Hopkins University Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
US4228099A (en) * 1978-03-17 1980-10-14 The Johns Hopkins University Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof

Also Published As

Publication number Publication date
EP0227545B1 (en) 1991-09-11
NO865217D0 (no) 1986-12-22
DK622486A (da) 1987-06-24
FI88581B (fi) 1993-02-26
NO865217L (no) 1987-06-24
CA1286990C (en) 1991-07-30
DK622486D0 (da) 1986-12-22
EP0227545A2 (en) 1987-07-01
AU592395B2 (en) 1990-01-11
FI865268A0 (fi) 1986-12-22
KR870005639A (ko) 1987-07-06
PT83995B (pt) 1989-09-14
ATE67088T1 (de) 1991-09-15
KR940002661B1 (ko) 1994-03-28
PT83995A (en) 1987-01-01
US4752619A (en) 1988-06-21
FI865268L (fi) 1987-06-24
JPS62270522A (ja) 1987-11-24
GR3003272T3 (en) 1993-02-17
DK168274B1 (da) 1994-03-07
AU6691786A (en) 1987-06-25
EP0227545A3 (en) 1988-01-20
FI88581C (fi) 1993-06-10
DE3681420D1 (de) 1991-10-17

Similar Documents

Publication Publication Date Title
ES2025560T3 (es) Un procedimiento para preparar una composicion para el tratamiento alimenticio.
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
DE69124223D1 (de) Vitamine und mineralien enthaltende nahrungszusätze
KR960703320A (ko) 가축을 위한 도살전 영양 첨가물(antemortem nutrient supplement for livestock)
FI904074A7 (fi) Optimoidun aminohappokoostumuksen omaavat proteiini-, peptidi- ja aminohapposeokset sekä niiden käyttö keskosten ja rintalasten ravinnon sekä äidinmaidon lisäaineiden valmistamiseksi
García-Meilán et al. Effects of dietary protein-to-lipid ratio on digestive and absorptive processes in sea bass fingerlings
EP0405295A3 (en) Improved nutritional formulation for the treatment of renal disease
AU1971988A (en) Pharmaceutical compositions for the treatment of uraemia
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
IT1247125B (it) Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco.
EA202193169A1 (ru) Препараты в форме мягких гелевых капсул на основе желатина с витаминами и минералами, включающие витамин с в форме соли аскорбата
PT74229A (de) Verwendung von waessrigen natrium-oder kaliummethioninat-loe- sungen zur supplementierung von mischfuttern mit methionin
DK0714910T3 (da) Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud
GEP19971020B (en) Composition for contact lenses processing
ES265913A1 (es) Procedimiento para la preparaciën de una composiciën para piensos de animales
MX9300469A (es) Procedimiento para preparar malato y composicion obtenida con el mismo.
DE69802789D1 (de) Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-carnitin-oder alkanoyl-l-carnitin mit 2-aminosulfonsäure enthalten
ES2054942T3 (es) Procedimiento para la determinacion de fructuosaminas.
GB1497211A (en) Soft moist animal diet feed
SU1630043A1 (ru) Плазмозамещающий раствор для лечения шока "мафусол"
JPS6460354A (en) Quality improver composition for sausage
ES2035781B1 (es) Alimentos de disolucion progresiva para la nutricion de animales acuaticos y procedimiento para su preparacion.
RU93012680A (ru) Белково-витаминно-минеральная добавка для свиней
ES2067058T3 (es) Tratamiento de carnes.
FI853504L (fi) Acetyldikarnitin.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 227545

Country of ref document: ES